Who owns Innate Pharma Adr?

Tip: Access positions for across all investors

Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Innate Pharma stock

Who bought or sold Innate Pharma Adr this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Optiver Holding B.V. 190k $481k 133% Sep 2023
 View chart
Exchange Traded Concepts 47k $131k 34% Dec 2023
 View chart
Morgan Stanley 45k $114k -4% Sep 2023
 View chart
Millennium Management 12k $34k -74% Dec 2023
 View chart
Barclays 412.00 $1.0k 0% Dec 2023
 View chart
Rhumbline Advisers 205.00 $574.000000 0% Dec 2023
 View chart
Steward Partners Investment Advisory 200.00 $560.000000 -60% Dec 2023
 View chart
UBS Group 146.00 $409.004400 0% Dec 2023
 View chart